Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Cash from Operations (2020 - 2025)

Historic Cash from Operations for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to $71.2 million.

  • Sotera Health's Cash from Operations fell 2698.63% to $71.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $239.8 million, marking a year-over-year decrease of 1483.18%. This contributed to the annual value of $224.2 million for FY2024, which is 25173.69% up from last year.
  • Sotera Health's Cash from Operations amounted to $71.2 million in Q3 2025, which was down 2698.63% from $57.4 million recorded in Q2 2025.
  • Sotera Health's 5-year Cash from Operations high stood at $113.1 million for Q4 2023, and its period low was -$336.6 million during Q2 2023.
  • In the last 5 years, Sotera Health's Cash from Operations had a median value of $58.3 million in 2022 and averaged $43.2 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first soared by 88697.72% in 2021, then plummeted by 67742.46% in 2023.
  • Quarter analysis of 5 years shows Sotera Health's Cash from Operations stood at $66.4 million in 2021, then soared by 53.62% to $101.9 million in 2022, then grew by 10.99% to $113.1 million in 2023, then plummeted by 50.75% to $55.7 million in 2024, then grew by 27.71% to $71.2 million in 2025.
  • Its Cash from Operations stands at $71.2 million for Q3 2025, versus $57.4 million for Q2 2025 and $55.5 million for Q1 2025.